Summit Therapeutics, Inc. Employee Directory
Biotechnology ResearchFlorida, United States201-500 Employees
Summit Therapeutics, Inc. operates in biotechnology research with a focus on developing medicinal therapies and managing the full development process—from discovery and trials to regulatory submission and commercialization. The therapies are intended to improve quality of life, extend potential lifespans, and address serious medical needs for patients, physicians, caregivers, and society at large. The company emphasizes accelerating development timelines while controlling costs and pursues commercialization or development partnerships when appropriate. Headquartered in Miami, Florida, the company was founded in 2003 and maintains additional offices in Palo Alto, Princeton, Oxford, and Dublin. Summit Therapeutics is listed on the Nasdaq Global Market under the ticker SMMT. Recent reporting notes a collaboration with Akeso to develop Ivonescimab for the US market.